In this study, we conduct an epigenome-wide methylation analysis to characterize the differential methylation of Pcyt2 + /- livers and investigate whether the attenuation of NASH with PEA treatment is associated with changes in DNA methylation. This evidence concerns the gene PCYT2 and metabolic dysfunction-associated steatohepatitis.